Related Experiment Video
Updated: Sep 29, 2025

06:30
Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
Published on: May 17, 2021
4.3K
Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models.
Patrícia Zoio1, Abel Oliva1,2
1Instituto de Tecnologia Química e Biológica (ITQB), Universidade Nova de Lisboa, Avenida da República, Estação Agronómica Nacional, 2780-157 Oeiras, Portugal.
Pharmaceutics
|March 26, 2022
Summary
Advanced skin-on-a-chip (SoC) devices offer physiologically relevant in vitro models for drug testing. This review explores their creation, challenges, and potential for clinical translation.
Area of Science:
- Biomedical Engineering
- Tissue Engineering
- Pharmacology
Background:
- Increasing demand for accurate in vitro human skin models for pharmaceutical drug testing.
- Limitations of conventional cell culture techniques in mimicking native skin microenvironments.
Purpose of the Study:
- To review the major challenges and key prerequisites for creating physiologically relevant skin-on-a-chip (SoC) devices for drug testing.
- To discuss technical and biological aspects of SoC device development.
- To highlight current challenges for clinical translation.
Main Methods:
- Review of recent advancements in skin-on-a-chip (SoC) device fabrication and sensor integration.
- Discussion of cell sourcing and scaffold materials for advanced skin models.
- Comparison and discussion of achievements and drawbacks of current SoC devices.
Main Results:
- Skin-on-a-chip (SoC) devices simulate key mechanical, functional, and structural features of human skin.
- SoC devices enable perfusion and real-time, non-destructive monitoring of skin function and drug effects.
- Significant progress has been made, but challenges remain for widespread clinical application.
Conclusions:
- Skin-on-a-chip (SoC) technology represents a promising advancement in in vitro drug testing models.
- Overcoming technical and biological hurdles is crucial for the clinical translation of SoC devices.
- Further research is needed to fully realize the potential of SoC for pharmaceutical development.

